These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9687221)

  • 1. Methotrexate treatment for Crohn's disease.
    Feagan BG
    Inflamm Bowel Dis; 1998 May; 4(2):120-1. PubMed ID: 9687221
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate for inflammatory bowel disease: time for reconsideration.
    Nielsen OH; Ainsworth MA; Steenholdt C
    Expert Rev Gastroenterol Hepatol; 2019 May; 13(5):407-409. PubMed ID: 30895827
    [No Abstract]   [Full Text] [Related]  

  • 3. Methotrexate for refractory Crohn's disease: preliminary answers to definitive questions.
    Kozarek RA
    Mayo Clin Proc; 1996 Jan; 71(1):104-5. PubMed ID: 8538222
    [No Abstract]   [Full Text] [Related]  

  • 4. Methotrexate: the best choice for second-line maintenance treatment in active Crohn's disease?
    Grimaldi C
    Gastroenterol Clin Biol; 2009 Jan; 33(1 Pt 1):21-2. PubMed ID: 18977624
    [No Abstract]   [Full Text] [Related]  

  • 5. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.
    Absah I; Faubion WA
    Inflamm Bowel Dis; 2012 Aug; 18(8):1488-92. PubMed ID: 21882301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of methotrexate in patients with inflammatory bowel diseases.
    Preiss JC; Zeitz M
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S151-5. PubMed ID: 21044450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2003; (1):CD003459. PubMed ID: 12535475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003459. PubMed ID: 15674908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trials in maintenance of remission in Crohn's disease.
    D'Incà R; Caccaro R
    Rev Recent Clin Trials; 2012 Nov; 7(4):270-83. PubMed ID: 23092231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C; Beau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis?
    Burakoff R
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S202-3. PubMed ID: 18816760
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
    Feagan BG; Fedorak RN; Irvine EJ; Wild G; Sutherland L; Steinhart AH; Greenberg GR; Koval J; Wong CJ; Hopkins M; Hanauer SB; McDonald JW
    N Engl J Med; 2000 Jun; 342(22):1627-32. PubMed ID: 10833208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate for Crohn's disease.
    Korelitz BI; Present DH
    N Engl J Med; 1995 Aug; 333(9):600-1. PubMed ID: 7623920
    [No Abstract]   [Full Text] [Related]  

  • 14. Methotrexate and maintenance of remission in Crohn's disease.
    Fishman M
    Can J Gastroenterol; 2001 Jul; 15(7):428. PubMed ID: 11493943
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical experience of methotrexate in Crohn's disease: response, safety and monitoring of treatment.
    Parker R; Dixit A; Fraser A; Creed TJ; Probert CS
    Postgrad Med J; 2010 Apr; 86(1014):208-11. PubMed ID: 20354043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators].
    Martreau P
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1243-4. PubMed ID: 11277090
    [No Abstract]   [Full Text] [Related]  

  • 17. The safety and tolerability of methotrexate for treating patients with Crohn's disease.
    Chande N; Abdelgadir I; Gregor J
    J Clin Gastroenterol; 2011 Aug; 45(7):599-601. PubMed ID: 21224737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V; Macdonald JK; McDonald JW; Chande N
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006884. PubMed ID: 19821390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological therapy as treatment of inflammatory bowel diseases].
    Agnholt J
    Ugeskr Laeger; 2008 Jun; 170(24):2152-6. PubMed ID: 18565302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.